Advertisement
Screener

Assembly Biosciences, Inc. (ASMB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Assembly Biosciences, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Assembly Biosciences, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $41.09M went out.
  • Fiscal year ended 2025-12-31: from investing, $113.47M went out.
  • Fiscal year ended 2025-12-31: from financing, $174.67M came in.
  • Fiscal year ended 2025-12-31: change in cash, $20.11M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingCommercial paperNew shares soldNot split outChange in cash
2025-12-31-$41.09M-$113.47M$1.92M$172.75M*$20.11M
2024-12-31-$51.12M$40.17M$2.03M$27.42M*$18.50M
2023-12-31$22.74M-$69.14M$4.55M$9.27M*-$32.58M
2022-12-31-$84.46M$90.64M$325.00K$6.79M
2021-12-31-$93.40M$26.52M$52.81M-$13.82M
2020-12-31-$62.96M$68.07M$5.45M$2.15M*$12.71M
2019-12-31-$84.07M-$50.32M$134.66M$4.99M*$5.26M
2018-12-31-$64.96M-$135.40M$155.43M$4.37M*-$40.56M
2017-12-31$1.86M-$15.64M$64.85M$2.39M*$53.46M
2016-12-31-$34.88M$36.20M$1.47M
2015-12-31-$18.70M-$64.86M$81.57M*-$1.98M
2014-12-31-$14.97M$277.40K$16.73M*$2.03M
2013-12-31-$17.80M-$6.48K$0.00$24.37M*$6.57M
2012-12-31-$21.38M-$3.24K$0.00$4.20M$696.82K*-$16.49M
2011-12-31-$25.07M-$11.96K-$419.38K$47.90M*$22.40M
2010-12-31-$5.21M$0.00$19.70M*$14.49M
2009-12-31-$3.48M$3.55M*$65.44K

Each quarter (3 month)

Quarter endRunning the businessFrom investingCommercial paperNew shares soldNot split outChange in cash
2026-06-30-$15.49M*-$92.08M*$0.00*$108.73M*
2026-03-31-$22.10M-$5.38M$0.00-$27.33M
2025-12-31$14.24M*$21.22M*$0.00*
2025-09-30-$15.13M*-$158.27M*$0.00*$171.93M*
2025-06-30-$16.76M*$16.99M*$0.00*
2025-03-31-$23.44M$6.59M$1.92M-$14.93M
2024-12-31-$407.00K*-$6.70M*$2.03M*$14.96M*
2024-09-30-$15.24M*$24.49M*$0.00*
2024-06-30-$17.10M*$5.11M*$0.00*$12.45M*
2024-03-31-$18.36M$17.27M$0.00-$1.09M
2023-12-31$73.65M*-$89.65M*$0.00*$9.19M*
2023-09-30-$13.85M*$18.88M*$0.00*
2023-06-30-$13.63M*-$8.37M*$54.00K*
2023-03-31-$23.43M$10.00M$4.49M-$8.94M
2022-12-31-$19.25M*$16.56M*$325.00K*
2022-09-30-$19.82M*$31.43M*$0.00*
2022-06-30-$17.89M*$9.60M*$0.00*
2022-03-31-$27.50M$33.05M$0.00-$5.55M
2021-12-31-$19.36M*-$8.48M*$2.60M*
2021-09-30-$18.88M*$20.07M*$10.05M*
2021-06-30-$21.81M*-$3.09M*$6.01M*
2021-03-31-$33.34M$18.02M$34.14M$18.81M
2020-12-31-$25.27M*$20.71M*$5.45M*
2020-09-30$10.65M*-$49.89M*$0.00*$843.00K*
2020-06-30-$23.12M*$76.55M*$0.00*$950.00K*
2020-03-31-$25.22M$20.69M$0.00-$4.41M
2019-12-31-$20.53M*-$95.02M*$134.66M*$2.75M*
2019-09-30-$18.59M*$7.82M*$1.39M*
2019-06-30-$21.00M*$25.45M*$191.00K*$515.00K*
2019-03-31-$23.94M$11.44M$140.00K-$12.36M
2018-12-31-$16.73M*-$62.16M*$0.00*$605.00K*-$78.28M*
2018-09-30-$16.68M*-$73.60M*$155.84M*$65.56M*
2018-06-30-$16.05M*$1.46M*$1.85M*-$12.74M*
2018-03-31-$15.50M-$1.10M$1.50M-$15.11M
2017-12-31-$9.77M*-$1.67M*$1.39M*$64.84M*$54.79M*
2017-09-30-$10.96M*-$1.51M*$300.00K*-$12.21M*
2017-06-30-$12.36M*-$19.12M*$100.00K*-$31.37M*
2017-03-31$34.94M$6.66M$600.00K$42.24M
2016-12-31-$11.04M*$15.67M*$4.78M*
2016-09-30-$7.86M*$11.32M*$3.45M*
2016-06-30-$6.77M*$6.71M*-$53.71K*
2016-03-31-$9.21M$2.50M-$6.71M
2015-12-31-$5.46M*-$3.84M*-$9.29M*
2015-09-30-$5.19M*-$12.19M*-$17.12M*
2015-06-30-$4.38M*-$48.80M*$10.64M*-$42.54M*
2015-03-31-$3.67M-$30.71K$70.67M*$66.96M
2014-12-31-$3.59M*-$211.44K*$14.96M*$11.16M*
2014-09-30-$3.88M*$491.43K*-$3.38M*
2014-06-30-$2.32M*$0.00*-$2.32M*
2014-03-31-$5.19M-$2.59K$1.76M*-$3.42M
2013-12-31-$5.39M*-$1.31K*-$5.16M*
2013-09-30-$4.66M*$0.00*$3.39M*-$1.27M*
2013-06-30-$3.38M*-$5.17K*-$3.38M*
2013-03-31-$4.37M$0.00$20.80M$16.38M
2012-12-31-$3.07M*-$1.00*$33.51K*-$3.07M*
2012-09-30-$5.28M*$0.00*$0.00*-$5.28M*
2012-06-30-$6.94M*-$3.24K*-$33.51K*$4.75M*-$2.22M*
2012-03-31-$6.09M$0.00*$4.20M*-$5.91M
2011-12-31-$16.33M*$0.00*$0.00*-$16.32M*
2011-09-30-$4.07M*$0.00*$0.00*$47.57M*-$1.57M*$41.93M*
2011-06-30-$2.85M*-$1.00*$0.00*-$2.63M*
2011-03-31-$1.81M-$11.96K-$419.38K$1.68M*-$570.53K
2010-12-31-$1.22M*$15.52M*$14.30M*
2010-09-30-$1.02M*$642.50K*-$378.65K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Evolus, Inc. (EOLS)United States$0.519B-13.32
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53